Showing results (281-290 of 320) with videos related to

Sort By:
Pageof 32
World Journal of Urology|November 24, 2017
Short-term outcome after cystectomy: comparison of early oral feeding in an enhanced recovery protocol and feeding using Bengmark nasojejunal tubeC S Voskuilen, E E Fransen van de Putte, J Bloos-van der Hulst, et al.
World Journal of Urology|May 22, 2016
Vimentin over-expression and carbonic anhydrase IX under-expression are independent predictors of recurrence, specific and overall survival in non-metastatic clear-cell renal carcinoma: a validation studyA Ingels, M Hew, F Algaba, et al.
Urology|May 29, 2002
Comparison of surveillance and retroperitoneal lymph node dissection in Stage I nonseminomatous germ cell tumorsJ R Spermon, T A Roeleveld, H G van der Poel, et al.
Insights Into Imaging|May 22, 2019
Cryoablation and immunotherapy: an overview of evidence on its synergyB M Aarts, E G Klompenhouwer, S L Rice, et al.
British Journal of Cancer|October 29, 2009
A trial of consent procedures for future research with clinically derived biological samplesE Vermeulen, M K Schmidt, N K Aaronson, et al.
Scientific Reports|March 28, 2025
Pathogen-specific stomatal responses in cacao leaves to Phytophthora megakarya and Rhizoctonia solaniInsuck Baek, Seunghyun Lim, Jae Hee Jang, et al.
Fungal Biology and Biotechnology|October 5, 2019
Draft genome sequence of fastidious pathogen Ceratobasidium theobromae, which causes vascular-streak dieback in Theobroma cacaoShahin S Ali, Asman Asman, Jonathan Shao, et al.
Mycological Research|August 1, 2006
Genetic variability and chromosome-length polymorphisms of the witches' broom pathogen Crinipellis perniciosa from various plant hosts in South AmericaJohana Rincones, Gabriel D Mazotti, Gareth W Griffith, et al.
European Journal of Biochemistry|December 5, 2003
Regulation of maize lysine metabolism and endosperm protein synthesis by opaque and floury mutationsRicardo A Azevedo, Catherine Damerval, Jacques Landry, et al.
British Journal of Cancer|June 5, 2003
Immunotherapy with concurrent subcutaneous GM-CSF, low-dose IL-2 and IFN-alpha in patients with progressive metastatic renal cell carcinomaN Verra, R Jansen, G Groenewegen, et al.
Pageof 32